Neuren is developing new therapies for neurodevelopmental disorders with high unmet need. Neuren Pharmaceuticals (ASX: NEU) is developing new therapies for debilitating neurodevelopmental disorders that are characterised by impaired connections and signalling between brain cells. Neuren Pharmaceuticals (ASX: NEU) is developing new therapies for debilitating neurodevelopmental disorders that are characterised by impaired connec...
Neuren is developing new therapies for neurodevelopmental disorders with high unmet need. Neuren Pharmaceuticals (ASX: NEU) is developing new therapies for debilitating neurodevelopmental disorders that are characterised by impaired connections and signalling between brain cells. Neuren Pharmaceuticals (ASX: NEU) is developing new therapies for debilitating neurodevelopmental disorders that are characterised by impaired connections and signalling between brain cells. Neuren is progressing the non-clinical studies required prior to commencing clinical trials in 2020.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.